Page 26 - Read Online
P. 26

Page 12 of 13                        Matsuoka et al. J Cancer Metastasis Treat 2018;4:6  I  http://dx.doi.org/10.20517/2394-4722.2017.85

               37.  Yamaguchi H, Satoh Y, Ishigami H, Kurihara M, Yatomi Y, Kitayama J. Peritoneal lavage CEA mRNA levels predict conversion
                   gastrectomy outcomes after induction chemotherapy with intraperitoneal paclitaxel in gastric cancer patients with peritoneal metastasis.
                   Ann Surg Oncol 2017;24:3345-52.
               38.  Kodera Y, Nakanishi H, Ito S, Yamamura Y, Fujiwara M, Koike M, Hibi K, Ito K, Tatematsu M, Nakao A. Prognostic significance of
                   intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of
                   carcinoembryonic antigen. Gastric Cancer 2005;8:142-8.
               39.  Sugita Y, Fujiwara Y, Taniguchi H, Mori T, Ishii T, Niwa H, Okada Y, Takiguchi S, Yasuda T, Yano M, Monden M. Quantitative
                   molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer. Int J Oncol 2003;23:1419-23.
               40.  Katsuragi K, Yashiro M, Sawada T, Osaka H, Ohira M, Hirakawa K. Prognostic impact of PCR-based identification of isolated tumour
                   cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection. Br J Cancer 2007;97:550-6.
               41.  Takata A, Kurokawa Y, Fujiwara Y, Nakamura Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y.
                   Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer.
                   World J Surg 2014;38:1107-11.
               42.  Yang B, O’Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov
                   AV, Simpson AJ, Longley BJ. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent
                   apoptosis in MAGE-positive cell lines. Cancer Res 2007;67:9954-62.
               43.  Jeon CH, Kim IH, Chae HD. Prognostic value of genetic detection using CEA and MAGE in peritoneal washes with gastric carcinoma
                   after curative resection: result of a 3-year follow-up. Medicine (Baltimore) 2014;93:e83.
               44.  Li J, Yang Y, Fujie T, Tanaka F, Mimori K, Haraguchi M, Ueo H, Mori M, Akiyoshi T. Expression of the MAGE gene family in human
                   gastric carcinoma. Anticancer Res 1997;17:3559-63.
               45.  Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K. Aberrant gene methylation is a biomarker
                   for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients. Ann Surg Oncol 2011;18:3013-9.
               46.  Di Leva G, Croce CM. The role of microRNAs in the tumorigenesis of ovarian cancer. Front Oncol 2014;3:153.
               47.  Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K, Kosaka T, Makino H, Akiyama H, Kunisaki C, Endo I.
                   Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS
                   One 2015;10:e0130472.
               48.  Radke S, Pirkmaier A, Germain D. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene
                   2005;24:3448-58.
               49.  Miwa T, Kanda M, Tanaka H, Tanaka C, Kobayashi D, Umeda S, Iwata N, Hayashi M, Yamada S, Fujii T, Fujiwara M, Kodera Y.
                   FBXO50 enhances the malignant behavior of gastric cancer cells. Ann Surg Oncol 2017;24:3771-9.
               50.  Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion,
                   apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006;231:20-7.
               51.  Li Z, Zhang D, Zhang H, Miao Z, Tang Y, Sun G, Dai D. Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in
                   peritoneal lavage of gastric cancer patients. Tumour Biol 2014;35:3463-70.
               52.  Mirigian LS, Makareeva E, Koistinen H, Itkonen O, Sorsa T, Stenman UH, Salo T, Leikin S. Collagen degradation by tumor-associated
                   trypsins. Arch Biochem Biophys 2013;535:111-4.
               53.  Fujimura T, Ohta T, Kitagawa H, Fushida S, Nishimura GI, Yonemura Y, Elnemr A, Miwa K, Nakanuma Y. Trypsinogen expression and
                   early detection for peritoneal dissemination in gastric cancer. J Surg Oncol 1998;69:71-5.
               54.  Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma L, Xue X, Wei G, Liu X, Fang G. The prevalence of Th17 cells in patients with gastric
                   cancer. Biochem Biophys Res Commun 2008;374:533-7.
               55.  Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Yasuoka H, Yamaue H.
                   Prognostic significance of IL-17 mRNA expression in peritoneal lavage in gastric cancer patients who underwent curative resection.
                   Oncol Rep 2014;31:605-12.
               56.  Bernardes de Jesus B, Blasco MA. Telomerase at the intersection of cancer and aging. Trends Genet 2013;29:513-20.
               57.  Da MX, Wu XT, Guo TK, Zhao ZG, Luo T, Qian K, Zhang MM, Wang J. Clinical significance of telomerase activity in peritoneal
                   lavage fluid from patients with gastric cancer and its relationship with cellular proliferation. World J Gastroenterol 2007;13:3122-7.
               58.  Sakakura C, Hagiwara A, Nakanishi M, Shimomura K, Takagi T, Yasuoka R, Fujita Y, Abe T, Ichikawa Y, Takahashi S, Ishikawa T,
                   Nishizuka I, Morita T, Shimada H, Okazaki Y, Hayashizaki Y, Yamagishi H. Differential gene expression profiles of gastric cancer cells
                   established from primary tumour and malignant ascites. Br J Cancer 2002;87:1153-61.
               59.  Gilbert J, Haber M, Bordow SB, Marshall GM, Norris MD. Use of tumor-specific gene expression for the differential diagnosis of
                   neuroblastoma from other pediatric small round-cell malignancies. Am J Pathol 1999;155:17-21.
               60.  Sakakura C, Takemura M, Hagiwara A, Shimomura K, Miyagawa K, Nakashima S, Yoshikawa T, Takagi T, Kin S, Nakase Y, Fujiyama
                   J, Hayasizaki Y, Okazaki Y, Yamagishi H. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its
                   potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br J Cancer 2004;90:665-71.
               61.  Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer
                   stem cells using the cell surface marker CD44. Stem Cells 2009;27:1006-20.
               62.  Horikawa M, Iinuma H, Inoue T, Ogawa E, Fukushima R. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically
                   separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients. Oncol
                   Rep 2011;25:1413-20.
               63.  Bachelor MA, Lu Y, Owens DM. L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation
   21   22   23   24   25   26   27   28   29   30   31